Skip to main content

Table 1 Demographic data of study patients. Data are presented as numbers (percentages) or median (interquartile range). Statistical significance was tested between respondents (n = 288) and non-respondents of quality of life questionnaire (EQ-5D) at one year

From: One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure

 

ARF patients

(n = 958)

One-year survivors (n = 619)

 
  

Respondents (n = 288)

Non-respondents (n = 331)

P value

Age, years

63 (51-74)

64 (53-74)

55 (41-66)

< 0.001

Gender, male n (%)

637 (66.5%)

195 (67.7%)

220 (66.5%)

0.74

SAPS II, points

43 (31-55)

37 (27-49)

37 (27-48)

0.99

SOFA, points

8 (6-10)

7 (5-9)

7 (5-9)

0.81

TISS, points, average

34 (29-41)

34 (29-43)

33 (28-39)

0.04

TISS, points, total

151 (90-280)

146 (95-271)

145 (78-264)

0.18

Operative n (%)

375 (39.1%)

143 (49.7%)

136 (41.1%)

0.03

Emergency n (%)

821 (85.7%)

217 (75.3%)

289 (87.3%)

< 0.001

Ventilatory support, days

2 (1-5)

2 (1-4)

2 (1-5)

0.81

ICU length of stay, days

3 (2-7)

3 (2-7)

3 (2-7)

0.29

Hospital length of stay, days

11 (6-21)

13 (8-23)

12 (7-23)

0.19

ALI/ARDS n (%)

68 (7.0%)

13 (4.5%)

20 (6.0%)

0.40

  1. ALI, acute lung injury; ARDS, adult respiratory distress syndrome; ARF, acute respiratory failure; SAPS II, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment; TISS, Therapeutic Intervention Scoring 76.